[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
April 18, 2001

Glycemic Control and Health Care Costs for Patients With Diabetes—Reply

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;285(15):1963-1964. doi:10.1001/jama.285.15.1963

In Reply: We have limited ability to test Dr Pogach's hypothesis that comorbid disorders such as depression contributed to problems in glycemic control and increased costs. But we were able to look at antidepressant prescriptions filled among the 2 cohorts in the baseline year (1992) and the following year. We found that 26% of the improved cohort and 22% of the unimproved cohort received 1 or more prescriptions for an antidepressant during the 2-year period, suggesting no increase in the prevalence of depression in the unimproved group. The evidence that we do have suggests that the improved cohort became less costly despite greater morbidity at baseline, providing support for better glycemic control as an explanation.

First Page Preview View Large
First page PDF preview
First page PDF preview
×